These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 38685519)

  • 1. Trends in RSV testing patterns among infants presenting with bronchiolitis: Results from four United States health systems, 2015-2023.
    Blatt AZ; Suh M; Walter EB; Wood CT; Espinosa C; Enriquez-Bruce ME; Domachowske J; Daniels D; Budhecha S; Elliott A; Wolf Z; Waddell EB; Movva N; Reichert H; Fryzek JP; Nelson CB
    Ann Epidemiol; 2024 Jun; 94():72-80. PubMed ID: 38685519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Geographic Progression of Infant Respiratory Syncytial Virus Associated Bronchiolitis Across the United States Before and Since the Onset of COVID-19: Results From Four Health Systems, 2015-2023.
    Blatt AZ; Suh M; Walter EB; Wood CT; Espinosa C; Enriquez-Bruce ME; Domachowske J; Daniels D; Budhecha S; Elliott A; Wolf Z; Waddell EB; Movva N; Reichert H; Fryzek JP; Nelson CB
    Influenza Other Respir Viruses; 2024 May; 18(5):e13298. PubMed ID: 38751165
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epidemiology of RSV Bronchiolitis Among Young Children in Central New York Before and After the Onset of the COVID-19 Pandemic.
    Daniels D; Wang D; Suryadevara M; Wolf Z; Nelson CB; Suh M; Movva N; Reichert H; Fryzek JP; Domachowske JB
    Pediatr Infect Dis J; 2023 Dec; 42(12):1056-1062. PubMed ID: 37725814
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic Literature Review of Respiratory Syncytial Virus Laboratory Testing Practices and Incidence in United States Infants and Children <5 Years of Age.
    Movva N; Suh M; Bylsma LC; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S213-S224. PubMed ID: 35968874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical Phenotype of Respiratory Syncytial Virus Bronchiolitis before and during the Coronavirus Disease 2019 Pandemic.
    Rodríguez-Fernández R; González-Martínez F; Perez-Moreno J; González-Sánchez MI; de la Mata Navazo S; Toledo Del Castillo B; Saavedra Lozano J; Voltas Espinosa L; Manso Perez S; Miñarro Berlanga M; Mejias A; Ramilo O
    Am J Perinatol; 2024 Mar; 41(4):515-521. PubMed ID: 36543242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Respiratory syncytial virus-related bronchiolitis in Puerto Rico.
    Molinari Such M; García I; García L; Puig G; Pedraza L; Marín J; Valcárcel M
    P R Health Sci J; 2005 Jun; 24(2):137-40. PubMed ID: 16116931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiological shifts in bronchiolitis patterns and impact of the COVID-19: A two-season comparative study.
    Presti S; Manti S; Gammeri C; Parisi GF; Papale M; Leonardi S
    Pediatr Pulmonol; 2024 May; 59(5):1298-1304. PubMed ID: 38353390
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Respiratory Syncytial Virus During the COVID-19 Pandemic Compared to Historic Levels: A Retrospective Cohort Study of a Health System.
    Movva N; Suh M; Reichert H; Hintze B; Sendak MP; Wolf Z; Carr S; Kaminski T; White M; Fisher K; Wood CT; Fryzek JP; Nelson CB; Malcolm WF
    J Infect Dis; 2022 Aug; 226(Suppl 2):S175-S183. PubMed ID: 35968868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Pediatric Respiratory Syncytial Virus Case Counts Following the Emergence of SARS-CoV-2 Can Be Attributed to Changes in Testing.
    Petros BA; Milliren CE; Sabeti PC; Ozonoff A
    Clin Infect Dis; 2024 Jun; 78(6):1707-1717. PubMed ID: 38602423
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Respiratory syncytial virus: can we still believe that after pandemic bronchiolitis is not a critical issue for public health?
    Vittucci AC; Antilici L; Russo C; Musolino AMC; Cristaldi S; Cutrera R; Persia S; Di Maio CV; Raponi M; Perno CF; Villani A
    Eur J Pediatr; 2023 Dec; 182(12):5303-5313. PubMed ID: 37728752
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in Respiratory Syncytial Virus and Bronchiolitis Hospitalization Rates in High-Risk Infants in a United States Nationally Representative Database, 1997-2012.
    Doucette A; Jiang X; Fryzek J; Coalson J; McLaurin K; Ambrose CS
    PLoS One; 2016; 11(4):e0152208. PubMed ID: 27050095
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Respiratory syncytial virus bronchiolitis in congenital diaphragmatic hernia: A systematic review of prevalence rates and palivizumab prophylaxis.
    Lewis L; Sinha I; Losty PD
    Pediatr Pulmonol; 2022 Jan; 57(1):239-244. PubMed ID: 34617409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variation in the seasonality of the respiratory syncytial virus during the COVID-19 pandemic.
    Bermúdez Barrezueta L; Matías Del Pozo V; López-Casillas P; Brezmes Raposo M; Gutiérrez Zamorano M; Pino Vázquez MA
    Infection; 2022 Aug; 50(4):1001-1005. PubMed ID: 35316529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mortality Associated With Respiratory Syncytial Virus, Bronchiolitis, and Influenza Among Infants in the United States: A Birth Cohort Study From 1999 to 2018.
    Reichert H; Suh M; Jiang X; Movva N; Bylsma LC; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S246-S254. PubMed ID: 35968877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Systematic Literature Review of the Burden of Respiratory Syncytial Virus and Health Care Utilization Among United States Infants Younger Than 1 Year.
    Suh M; Movva N; Bylsma LC; Fryzek JP; Nelson CB
    J Infect Dis; 2022 Aug; 226(Suppl 2):S195-S212. PubMed ID: 35968876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of public health measures during the SARS-CoV-2 pandemic on the winter respiratory syncytial virus epidemic: An interrupted time series analysis.
    Reyes Domínguez AI; Pavlovic Nesic S; Urquía Martí L; Pérez González MDC; Reyes Suárez D; García-Muñoz Rodrigo F
    Paediatr Perinat Epidemiol; 2022 May; 36(3):329-336. PubMed ID: 34981845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. How has the SARS-CoV-2 pandemic changed the epidemiology and management of acute bronchiolitis?
    Brisca G; Mariani M; Buratti S; Ferretti M; Pirlo D; Buffoni I; Mallamaci M; Salvati P; Tagliarini G; Piccotti E; Sacco O; Castagnola E; Moscatelli A
    Pediatr Pulmonol; 2023 Apr; 58(4):1169-1177. PubMed ID: 36636959
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Healthcare costs within a year of respiratory syncytial virus among Medicaid infants.
    Palmer L; Hall CB; Katkin JP; Shi N; Masaquel AS; McLaurin KK; Mahadevia PJ
    Pediatr Pulmonol; 2010 Aug; 45(8):772-81. PubMed ID: 20632403
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Examining the interseasonal resurgence of respiratory syncytial virus in Western Australia.
    Foley DA; Phuong LK; Peplinski J; Lim SM; Lee WH; Farhat A; Minney-Smith CA; Martin AC; Mace AO; Sikazwe CT; Le H; Levy A; Hoeppner T; Borland ML; Hazelton B; Moore HC; Blyth C; Yeoh DK; Bowen AC
    Arch Dis Child; 2022 Mar; 107(3):e7. PubMed ID: 34433552
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical relevance of viral codetection in infants with respiratory syncytial virus bronchiolitis.
    Bernet Sánchez A; Bellés Bellés A; García González M; Minguell Domingo L; Solé Mir E
    Enferm Infecc Microbiol Clin (Engl Ed); 2024; 42(6):308-312. PubMed ID: 37468350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.